Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling
- PMID: 23715499
- DOI: 10.1093/carcin/bgt182
Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling
Abstract
Glycogen synthase kinase 3β (GSK3β) is a serine/threonine protein kinase involved in human cancers including glioblastoma. We have previously demonstrated that GSK3β inhibition enhances temozolomide effect in glioma cells. In this report, we investigated the molecular mechanisms of sensitization of glioblastoma cells to temozolomide by GSK3β inhibition, focusing on O(6)-methylguanine DNA methyltransferase (MGMT) gene silencing. Glioblastoma tissues from patients treated with the GSK3β-inhibiting drugs were subjected to immunohistochemistry and methylation-specific PCR assay. Human glioblastoma cell lines T98G, U138, U251 and U87 were treated with a small-molecule GSK3β inhibitor, AR-A014418 or GSK3β-specific small interfering RNA. The combined effect of temozolomide and AR-A014418 on cell proliferation was determined by AlamarBlue assay and an isobologram method. MGMT promoter methylation was estimated by methylation-specific PCR and MethyLight assay. MGMT gene expression was evaluated by real-time quantitative reverse transcriptase-PCR. c-Myc and DNA (cytosine-5)-methyltransferase 3A binding to the MGMT promoter was estimated by chromatin immunoprecipitation assay. GSK3β inhibition decreased phosphorylation of glycogen synthase and reduced MGMT expression and increased MGMT promoter methylation in clinical tumors. In glioblastoma cell lines, GSK3β inhibition decreased cell viability, enhanced temozolomide effect and downregulated MGMT expression with relevant changes in the methylation levels of the MGMT promoter. Here, we showed for the first time that c-Myc binds to the MGMT promoter with consequent recruitment of DNA (cytosine-5)-methyltransferase 3A, regulating the levels of MGMT promoter methylation. The results of this study suggest that GSK3β inhibition enhances temozolomide effect by silencing MGMT expression via c-Myc-mediated promoter methylation.
Similar articles
-
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).Int J Oncol. 2015 Aug;47(2):417-28. doi: 10.3892/ijo.2015.3026. Epub 2015 May 29. Int J Oncol. 2015. PMID: 26035292 Free PMC article. Review.
-
Impact of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine resistance of Hodgkin's lymphoma cells.Leuk Res. 2014 Jan;38(1):138-43. doi: 10.1016/j.leukres.2013.11.001. Epub 2013 Nov 13. Leuk Res. 2014. PMID: 24284332
-
O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.Neurosurgery. 2010 Dec;67(6):1681-91. doi: 10.1227/NEU.0b013e3181f743f5. Neurosurgery. 2010. PMID: 21107199 Review.
-
Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.J Natl Cancer Inst. 2006 Jan 4;98(1):38-50. doi: 10.1093/jnci/djj003. J Natl Cancer Inst. 2006. PMID: 16391370
-
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.Clin Cancer Res. 2004 Mar 15;10(6):1871-4. doi: 10.1158/1078-0432.ccr-03-0384. Clin Cancer Res. 2004. PMID: 15041700 Clinical Trial.
Cited by
-
The many faceted role of glycogen synthase kinase-3 (GSK-3) in T cells and cancer immunotherapy.J Cancer Biol. 2024;5(1):11-16. doi: 10.46439/cancerbiology.5.058. J Cancer Biol. 2024. PMID: 38813058 Free PMC article. No abstract available.
-
MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma.Sci Rep. 2024 May 29;14(1):12363. doi: 10.1038/s41598-024-61240-x. Sci Rep. 2024. PMID: 38811596 Free PMC article.
-
The "Superoncogene" Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme.Int J Mol Sci. 2023 Feb 20;24(4):4217. doi: 10.3390/ijms24044217. Int J Mol Sci. 2023. PMID: 36835628 Free PMC article. Review.
-
Long non-coding RNA in glioma: novel genetic players in temozolomide resistance.Anim Cells Syst (Seoul). 2023 Feb 15;27(1):19-28. doi: 10.1080/19768354.2023.2175497. eCollection 2023. Anim Cells Syst (Seoul). 2023. PMID: 36819921 Free PMC article. Review.
-
Decrypting a path based approach for identifying the interplay between PI3K and GSK3 signaling cascade from the perspective of cancer.Genes Dis. 2022 Feb 22;9(4):868-888. doi: 10.1016/j.gendis.2021.12.025. eCollection 2022 Jul. Genes Dis. 2022. PMID: 35685456 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous